A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

Comparing the PK similarity of BAT3306 and Keytruda; in NSCLC participants who were completely removed by surgery as an auxiliary treatment

Trial Details

NCT ID
NCT07180862
Phase
PHASE1
Sponsor
Bio-Thera Solutions
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • BAT3306
  • US-Keytruda®
Locations (sample)
  • Wuhan, Hubei, China|30.58333,114.26667

Key Eligibility Criteria

  • Participants must meet all of the following criteria:
  • Male or female, aged ≥18 and ≤75 years on the day of signing the Informed Consent Form (ICF);
  • Participants are able to give voluntary informed consent and understand the study and are willing to follow and complete all the test procedures;
  • Pathologically confirmed non-small cell lung cancer (NSCLC) after surgery, with a clear histological type and a pathology report provided;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →